US2004265928A1PendingUtilityA1
Polynucleotides differentially expressed in adenocarcinomas, polypeptides encoded thereby, and methods of use thereof
Priority: Jul 26, 1999Filed: Jan 22, 2004Published: Dec 30, 2004
Est. expiryJul 26, 2019(expired)· nominal 20-yr term from priority
Inventors:Giulia C. Kennedy
A01K 2217/075C07K 14/47A01K 2217/05
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention features human HX2004-6 polypeptide and nucleotide sequences encoding HX2004-6 polypeptides. In a particular aspect, the polynucleotide is the nucleotide sequence of SEQ ID NO: 1. In related aspects the invention features expression vectors and host cells comprising polynucleotides that encode a human HX2004-6 polypeptide. The present invention also relates to antibodies that bind specifically to a human HX2004-6 polypeptide. Further provided are diagnostic and screening methods using HX2004-6 polynucleotides and antibodies specific for HX2004-6 polypeptides.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An isolated human HX2004-6 polypeptide.
2 . The human HX2004-6 polypeptide of claim 1 , comprising an amino acid sequence of SEQ ID NO:2.
3 . The human HX2004-6 polypeptide of claim 1 , which has an amino acid sequence of amino acids 1-342 of SEQ ID NO:2.
4 . An isolated polynucleotide, or complement thereof, comprising a polynucleotide sequence encoding a human HX2004-6 polypeptide of claim 1 .
5 . The isolated polynucleotide sequence of claim 4 comprising a polynucleotide sequence of SEQ ID NO:1.
6 . The isolated polynucleotide sequence of claim 4 having a polynucleotide sequence of nucleotides 1-1724of SEQ ID NO:1.
7 . An isolated polynucleotide sequence which hybridizes under stringent conditions to a polynucleotide having the sequence depicted in SEQ ID NO:1.
8 . An isolated polynucleotide sequence which hybridizes under stringent conditions to a polynucleotide having the sequence of nucleotides 1-1724 of SEQ ID NO: 1.
9 . An isolated polynucleotide of claim 4 , wherein said polynucleotide is overexpressed in an adenocarcinoma of a tissue selected from the group consisting of exocrine pancreas, breast, and colon.
10 . A recombinant expression vector comprising the polynucleotide sequence of claim 4 .
11 . An isolated host cell comprising the polynucleotide sequence of claim 4 .
12 . A method for producing the human HX2004-6 polypeptide of claim 1 , the method comprising the steps of:
a) culturing a recombinant host cell containing a human HX2004-6 polypeptide-encoding polynucleotide sequence under conditions suitable for the expression of the polypeptide; and b) recovering the polypeptide from the host cell culture.
13 . An isolated antibody that specifically binds a human HX2004-6 polypeptide of claim 1 .
14 . A method for identifying a polynucleotide homologous to the polynucleotide of claim 4 , the method comprising the steps of:
contacting a polynucleotide probe with a test polynucleotide, the probe comprising at least 15 contiguous nucleotides of a polynucleotide sequence encoding a human HX2004-6 polypeptide; and detecting hybridization of the probe with the test polynucleotide; wherein detection of hybridization of the probe to the test polynucleotide indicates that the polynucleotide shares sequence homology with the human HX2004-6 polypeptide-encoding polynucleotide.
15 . A method of detecting the presence of an HX2004-6 mRNA in a biological sample, comprising:
a) contacting the sample with an HX2004-6 polynucleotide; and b) detecting hybridization.
16 . The method of claim 15 , wherein the sample is ductal epithelial cells from a tissue selected from the group consisting of pancreas, colon, and breast.
17 . The method of claim 15 , further comprising, before step (a) the step of making a cDNA copy of the HX2004-6 mRNA.
18 . A method for detecting the presence of an HX2004-6 polypeptide in a biological sample, comprising:
a) contacting the sample with an antibody specific for an HX2004-6 polypeptide; and b) detecting specific binding of the antibody.
19 . A method for identifying an agent that modulates HX2004-6 expression in a cell, the method comprising:
combining a candidate agent with a cell comprising a nucleic acid encoding a human HX2004-6 polypeptide; and determining the effect of said agent on HX2004-6 expression.
20 . The method of claim 19 , wherein said determining is carried out by measuring an amount of an HX2004-6 mRNA in the cell.
21 . The method of claim 19 , wherein said determining is carried out by measuring an amount of an HX2004-6 polypeptide in the cell.Join the waitlist — get patent alerts
Track US2004265928A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.